expert roundtables

Facing the Challenge of Persistent Moderate Disease Activity Despite Biologic Therapy
Rheumatology

Facing the Challenge of Persistent Moderate Disease Activity Despite Biologic Therapy

expert roundtables
By Eric M. Ruderman, MD; Jeffrey R. Curtis, MD, MS, MPH; Leonard H. Calabrese, DO
Use of Prognostic Factors to Guide the Treatment of Patients With Mantle Cell Lymphoma
Oncology

Use of Prognostic Factors to Guide the Treatment of Patients With Mantle Cell Lymphoma

expert roundtables
By Brad Kahl, MD; Julie M. Vose, MD, MBA, FASCO; Thomas J. Kipps, MD, PhD
Treatment Options for Patients With Early Relapse of Mantle Cell Lymphoma
Oncology

Treatment Options for Patients With Early Relapse of Mantle Cell Lymphoma

expert roundtables
By Brad Kahl, MD; Julie M. Vose, MD, MBA, FASCO; Thomas J. Kipps, MD, PhD
Current Treatment Options for Older Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia
Oncology

Current Treatment Options for Older Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia

expert roundtables
By Bruce D. Cheson, MD, FACP, FAAAS, FASCO; Jennifer R. Brown, MD, PhD
Overcoming Immunodeficiency in Chronic Lymphocytic Leukemia
Oncology

Overcoming Immunodeficiency in Chronic Lymphocytic Leukemia

expert roundtables
By Bruce D. Cheson, MD, FACP, FAAAS, FASCO; Jennifer R. Brown, MD, PhD
Load More